CDCA2 and neoplasm: CDCA2 overexpression in hepatocellular carcinoma and colorectal cancer has also been associated with increased tumor cell proliferation, invasive behavior, and resistance to apoptosis, indicating a role in promoting treatment resistance [35, 36].